Single-nucleotide variations in C13orf31 (LACC1) that encode p.C284R and p.I254V in a protein of unknown function (called 'FAMIN' here) are associated with increased risk for systemic juvenile idiopathic arthritis, leprosy and Crohn's disease. Here we set out to identify the biological mechanism affected by these coding variations. FAMIN formed a complex with fatty acid synthase (FASN) on peroxisomes and promoted flux through de novo lipogenesis to concomitantly drive high levels of fatty-acid oxidation (FAO) and glycolysis and, consequently, ATP regeneration. FAMIN-dependent FAO controlled inflammasome activation, mitochondrial and NADPH-oxidase-dependent production of reactive oxygen species (ROS), and the bactericidal activity of macrophages. As p.I254V and p.C284R resulted in diminished function and loss of function, respectively, FAMIN determined resilience to endotoxin shock. Thus, we have identified a central regulator of the metabolic function and bioenergetic state of macrophages that is under evolutionary selection and determines the risk of inflammatory and infectious disease.
Immunological and inflammatory diseases arise from complex environment-gene interactions. While the external triggers remain unknown, human genetic studies have revealed the genomic-risk 'landscapes' of these conditions. Genes encoding proteins with established immunological function have been predictably identified as plausible candidates at various risk loci. The mechanistic contribution of their polymorphic variants to disease pathophysiology has been addressed experimentally for a few of these genes, although this is currently based largely on conjecture for most. Furthermore, for a large number of risk loci and genes, it remains entirely unclear how their products are mechanistically involved in disease, including some for which no biological function is known yet at all. We hypothesized that studying uncharacterized gene products singled out by genetic disease association might reveal novel biological mechanisms that are important not only for human health but also for mammalian biology in general.
Two coding polymorphisms in C13orf31 (LACC1), an open reading frame that encodes a protein of unknown function, render this gene and its product particularly notable. First, homoallelic carriage of a rare missense mutation at g.43,883,879T>C, which leads to substitution of arginine for cysteine at position 284 (p.C284R), has been linked in consanguineous families to systemic juvenile idiopathic arthritis (sJIA) (a periodic fever syndrome) and to early-onset Crohn's disease (CD) (an inflammatory bowel disease) 1, 2 . Second, the haplotype identified by the common single-nucleotide polymorphism (SNP) rs3764147 (g. 43,883,789A>G) , which leads to substitution of valine for isoleucine at position 254 (p.I254V), has been associated with increased risk for leprosy (an infection caused by Mycobacterium leprae) and CD 3, 4 .
Here we found that the protein encoded by that open reading frame served as 'rheostat' for the synthesis of endogenous fatty acids and their mitochondrial oxidation and thereby controlled glycolytic activity and overall ATP regeneration. As a consequence, the product of this polymorphic gene determined the mitochondrial and nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase-dependent production of reactive oxygen species (ROS), bactericidal activity and inflammasome activation in macrophages. These findings prompted us to call this protein 'FAMIN' ('fatty acid metabolism-immunity nexus').
RESULTS

Interaction of FAMIN with fatty acid synthase
C13orf31 mRNA has its highest expression in macrophages and is predicted to encode a cytoplasmic protein of 430 amino acids that lacks similarity to other mammalian protein families 5, 6 . We performed an unbiased proteomics search for interaction partners to begin to elucidate FAMIN's function. After discounting proteins involved in the synthesis, folding and degradation of proteins or cytoskeletal organization, we found that fatty acid synthase (FASN; EC 2.3.1.85) was the most abundant peptide detected with FAMIN tagged with Strep-tag at the amino or carboxyl terminus, expressed as 'bait' in HEK293T human embryonic kidney cells ( Supplementary Fig. 1 and Supplementary Table 1) . Endogenous FAMIN reciprocally immunoprecipitated together with FASN in lysates of primary human monocytes differentiated into macrophages, as well as in lysates of THP-1 and U937 human monocytic cell lines differentiated into macrophages (Fig. 1a) . A proximity-ligation assay (PLA) further confirmed the co-localization of FAMIN and FASN in situ (Fig. 1b) . The two common polymorphic FAMIN variants with either isoleucine (p.254I) or valine (p.254V) at amino acid position 254 exhibited equivalent interaction with FASN in co-immunoprecipitation experiments with lysates of HEK293T cells transfected with vector expressing FAMIN (Fig. 1c) , which further confirmed that FAMIN was in a complex with FASN.
Mammalian FASN is a large cytoplasmic polypeptide multienzyme central to de novo lipogenesis (DNL) 7 . FASN associates with membranes in various subcellular compartments 8 . We therefore performed confocal microscopy to determine the intracellular localization of FAMIN in macrophages differentiated from primary human monocytes and THP-1 cells. Immunofluorescence analysis revealed nearly perfect co-localization of FAMIN with the peroxisome markers PMP70 and catalase ( Fig. 1d and Supplementary  Fig. 2a-c) , while it had little co-localization with other organelle markers ( Supplementary Fig. 2d,e) . Co-localization between FAMIN and PMP70 was confirmed by PLA ( Fig. 1e and Supplementary Fig. 2f) ; this confirmed the peroxisomal localization of FAMIN.
Peroxisomes are organelles involved in lipid metabolism that are closely associated with lipid droplets and mitochondria 9 . Macrophages exhibit metabolic and functional plasticity, epitomized by in vitro culture under non-polarizing (M0), classical (M1) or alternative (M2) activation conditions 10 . While aerobic glycolysis is a defining characteristic of 'inflammatory' M1 macrophages and is their chief mechanism for the generation of ATP 11 , 'regenerative' M2 macrophages rely on mitochondrial fatty-acid oxidation (FAO; also called 'β-oxidation') to fuel oxidative phosphorylation 12 . To study FAMIN's function, we generated mice in which we knocked out alleles of Lacc1 (9030625A04Rik, the mouse homolog of the human gene C13orf31; called 'mFamin' here) 13 ( Supplementary Fig. 3 ). Similar to FAMIN, FASN does not have a peroxisomal localization motif and has been shown to form a complex with PMP70 on the cytoplasmic side of peroxisomes 9, 14 . Consistent with that, we found that a portion of cellular FASN immunoreactivity localized together with catalasepositive peroxisomes in mFamin +/+ M1 macrophages (20% ± 3% (mean ± s.e.m.)) and M2 macrophages (4% ± 2%), and this was not (Fig. 1f,g ). PLA confirmed those spatial relationships (Fig. 1h,i) . Bone-marrow-derived macrophages cultured under M0, M1 or M2 conditions all expressed mFamin mRNA, with the highest expression in cells differentiated under M1 conditions (Supplementary Fig. 4a ). Expression of Fasn mRNA was similar in mFamin +/+ macrophages and mFamin −/− macrophages, with the highest expression in cells cultured under M2 conditions (Supplementary Fig. 4b ). In addition, expression of FASN protein was also equivalent in mFamin +/+ M1 and M2 macrophages and their mFamin −/− counterparts (Supplementary Fig. 4c ). Together our data indicated that FAMIN and FASN formed a complex on peroxisomes and that the peroxisomal localization of FASN, particularly prominent in M1 macrophages, was not impaired in mFamin −/− cells.
Control of carbon flux via DNL by FAMIN
FASN catalyzes all steps in the synthesis of long-chain saturated fatty acids (LCFAs) (predominantly C16:0 palmitic acid) 15 . This enzymatic reaction utilizes cytoplasmic acetyl-coenzyme A (acetylCoA), malonyl-CoA (generated from acetyl-CoA by carboxylation) and NADPH 15 . Cytoplasmic acetyl-CoA is itself generated by ATP citrate lyase after the export of mitochondrial citrate formed during glucose-or amino-acid-fueled Krebs-cycle activity 16 . In consequence, FASN function allows the storage of excess energy, derived from glucose and amino-acid oxidation, in lipid droplets after the activation of LCFA and its esterification to LCFA-CoA and thence to triacylglycerol 17 . FASN also synthesizes fatty-acyl moieties of membrane lipids and provides the precursors of many other cellular and signaling lipids. Given the diverse functions of lipid moieties that are dependent on FASN function, precise channeling of its products into distinct metabolic pathways is essential 15, 17 .
To assess FASN activity in situ, we pulse labeled mouse bonemarrow-derived macrophages with [ 13 C 1,2 ]-glucose ( Supplementary   Fig. 5a ). Uptake of 13 C into total LCFAs and palmitic acid was below the limit of detection in mFamin +/+ and mFamin −/− M1 and M2 macrophages (data not shown), consistent with limited turnover and exogenous uptake of the large pools of free fatty acids. However, we did observe incorporation of 13 C into C16:0 and C18:1 fatty-acylCoA esters (the activated forms of LCFAs used for lipid synthesis and mitochondrial oxidation) in mFamin +/+ M1 and M2 macrophages ( Fig. 2a-d) . Together these data indicated that newly synthesized fatty acids were immediately esterified to CoA for subsequent use and thus did not determine the abundance of the free-fatty-acid pool. Furthermore, we discovered that the incorporation of 13 C into C18:1-CoA in M1 macrophages and into C16:0-CoA and C18:1-CoA in M2 macrophages was much lower in mFamin −/− cells than in mFamin +/+ cells ( Fig. 2a-d) . The abundance of total LCFA-CoA was also significantly lower in mFamin −/− M1 and M2 macrophages than in their mFamin +/+ counterparts (Fig. 2e,f) , while total fatty-acid content, including palmitic acid, was predictably indistinguishable in cells of these genotypes (Supplementary Table 2 ). Together these data indicated that FAMIN determined, via DNL, the availability of fattyacyl-CoA for processes such as FAO.
FAO requires the transport of CoA-activated LCFAs across mitochondrial membranes as acyl-carnitine esters 18 . The exchange of CoA for carnitine by the cytoplasmic carnitine palmitoyltransferase CPT1a is the rate-limiting step of FAO 18 . Consistent with the diminished specific availability of fatty-acyl-CoA, the incorporation of [ 13 C 1,2 ]glucose-derived 13 C into fatty-acyl carnitine species (total and C16:0) was much lower in mFamin −/− M2 macrophages than in mFamin +/+ M2 macrophages (Fig. 2g,h ), while its incorporation was below the limit of detection in M1 macrophages (data not shown). Notably, while the incorporation of glucose-derived 13 C into acyl-CoA was substantial after a 24-hour pulse (~20-30% of C16:0-CoA and C18:1-CoA in mFamin +/+ M2 macrophages), it was low npg for acyl carnitine species (~4% of total acyl carnitine in mFamin +/+ M2 macrophages) at the same time point (Fig. 2g,h ). Collectively, these results indicated FAMIN directly controlled the flux of glucose-derived carbon into DNL and onward into acyl carnitine, with the latter possibly involving an intermediary step via triacylglycerols 12 .
Control of glycolysis by FAMIN via DNL
To determine whether loss of FAMIN consequently influenced glycolytic metabolism in macrophages, we measured the extracellular acidification rate (ECAR), an indicator of glycolysis 19 , in wild-type and mutant macrophages. We found that the ECAR was much lower in mFamin −/− M1 macrophages than in mFamin +/+ M1 macrophages, with a similar proportional decrease from the expected lower baseline in M0 and M2 macrophages ( Fig. 2i-k) . The difference in the ECAR was further enhanced after blockade of the F 0 subunit of mitochondrial ATP synthase with oligomycin A (Fig. 2i-k) , which stimulates the alternative generation of ATP via glycolysis 20 . This observation indicated that FAMIN-dependent glycolysis was maximized under conditions in which mitochondrial respiration was uncoupled from ATP synthesis. Differences between mFamin +/+ macrophages and mFamin −/− macrophages in their ECAR were abolished after inhibition of glycolysis with 2-deoxy-dglucose ( Fig. 2i-k) . Similarly, measurement of ECAR in the presence of exogenous pyruvate, which bypasses glycolysis, showed that the ECAR of mFamin −/− macrophages was indistinguishable from that of mFamin +/+ macrophages ( Supplementary Fig. 5b ). Together these data demonstrated that FAMIN determined the baseline and maximal glycolytic capacity of macrophages. Notably, the intracellular concentration of citrate, which itself inhibits glycolysis at the level of phosphofructokinase 21 , was substantially higher in mFamin −/− macrophages differentiated under M1 conditions than in their mFamin +/+ counterparts (Fig. 2l) . The abundance of Krebscycle intermediates other than citrate in mFamin −/− M1 and M2 macrophages remained indistinguishable from that in their mFamin +/+ counterparts ( Supplementary Fig. 5c ), which indicated an absence of direct effects of FAMIN on Krebs-cycle activity. Collectively, these results indicated that the impairment in glycolysis might have been a consequence of defective DNL.
Promotion of mitochondrial FAO by FAMIN
Since we had observed that the extent of carbon flux through DNL into acyl carnitine was determined by FAMIN, we hypothesized that FAMIN might control mitochondrial FAO. As expected, mFamin +/+ M2 macrophages had high basal oxidative phosphorylation, as reflected by their high oxygen-consumption rate (OCR), whereas M1 macrophages had a low OCR that was refractory to treatment with oligomycin, an inhibitor of ATP synthase ( Fig. 3a-d) . Impaired glycolysis usually leads to a compensatory increase in oxidative phosphorylation for the maintenance of ATP intracellular concentrations 22 . However, in addition to their defective glycolysis, mFamin −/− M1 and M2 macrophages also concomitantly exhibited significantly lower basal OCR than that of their mFamin +/+ counterparts ( Fig. 3a-d) . Maximal uncontrolled OCR (MU-OCR) is elicited by dissipation of the mitochondrial electrochemical proton gradient with the mitochondrial uncoupler FCCP (carbonyl-cyanide p-tri-fluoro-methoxy-phenylhydrazone), which also 'unmasks' the spare respiratory capacity (SRC) (the difference between maximal capacity and basal respiratory capacity) 12 . The MU-OCR was diminished and SRC could not be elicited in mFamin −/− M2 macrophages following uncoupling via FCCP (Fig. 3b,e) . Complete inhibition of mitochondrial respiration via rotenone and antimycin A (inhibitors of electron-transport chain complexes I and III, respectively) abolished the differences between mFamin −/− macrophages and mFamin +/+ macrophages in their OCR A r t i c l e s ( Fig. 3a,b ). Together these data demonstrated that mFamin −/− M1 and M2 macrophages exhibited diminished oxidative capacity in not only basal respiratory states but also uncoupled respiratory states. A high basal OCR and SRC in M2 macrophages has been reported to be secondary to FAO 12 . We therefore considered defective FAO as the cause for the impaired OCR that was particularly apparent in mFamin −/− M2 macrophages. To test the hypothesis that FAMIN specifically affects mitochondrial FAO and not oxidative phosphorylation fueled by other substrates, we inhibited the activity of CPT1a. Genetic silencing of Cpt1a or blocking CPT1a with the irreversible inhibitor etomoxir 23 decreased the OCR in mFamin +/+ M2 macrophages to that in mFamin −/− M2 macrophages ( Fig. 3f and Supplementary  Fig. 5d ). Notably, silencing Cpt1a in mFamin +/+ M1 and M2 macrophages reduced their basal ECAR to the low ECAR in mFamin −/− macrophages, while silencing Cpt1a in mFamin −/− cells did not diminish the ECAR any further (Fig. 3g,h ). In summary, our findings demonstrated that loss of FAMIN led to decreased FAO that was needed to sustain high rates of glycolysis. (Fig. 3a-e) . Notably, blockade of FASN with C75 decreased ECAR in both mFamin +/+ M1 macrophages and mFamin +/+ M2 macrophages and abolished the mFamin-genotype-related differences in ECAR (Fig. 4a,b) . To provide further support for those findings, we measured OCR under conditions devoid of exogenous lipids, in which FAO is thus entirely dependent upon lipids synthesized de novo by FASN. As observed under lipid-replete conditions above, baseline OCR and MU-OCR were lower in mFamin −/− M2 macrophages than in mFamin +/+ M2 macrophages during culture in the absence of exogenous lipids, and these differences were abolished by inhibition of CPT1a with etomoxir ( Fig. 4c) . Supplementation with exogenous palmitic acid increased the basal OCR and MU-OCR in mFamin −/− M2 macrophages to levels equivalent to those in mFamin +/+ M2 macrophages ( Fig. 4d) , which demonstrated that exogenous palmitic acid was able to 'rescue' the lower basal and maximum OCR in 'starved' mFamin −/− M2 macrophages. Finally, blockade of CPT1a in M2 macrophages supplemented with exogenous palmitic acid decreased the basal OCR and MU-OCR in mFamin +/+ cells to rates identical to those in mFamin −/− cells (Fig. 4e) . These data demonstrated that FAMIN supported FAO and glycolysis via a mechanism that involved DNL.
Control of macrophage energy stores by FAMIN
Given that FAMIN controlled the extent of FAO and glycolysis in parallel and, notably, that these processes did not 'cross-compensate' for each other's diminished function, we hypothesized that FAMIN's function would affect macrophage energy stores. The total cellular ATP was much lower in bone-marrow-derived mFamin −/− M1 and M2 macrophages than in their mFamin +/+ counterparts (a decrease of 30% ± 12% and 26% ± 6% (mean ± s.e.m.), respectively; Fig. 4f ). The concentration of cellular phosphocreatine, a rapidly mobilizable energy store, was similarly lower in mFamin −/− M1 and M2 macrophages than in their mFamin +/+ counterparts ( Fig. 4g) . Transmission electron microscopy demonstrated morphological changes in the mitochondria of mFamin −/− macrophages, characterized by elongation and narrowing (consistent with adaptation in response to ATP depletion), relative to the morphology of mitochondria in mFamin +/+ macrophages 25 (Fig. 5a,b) . Hence, FAMIN promoted glycolysis, FAO and, consequently, cellular energy stores in macrophages.
FAMIN and macrophage ROS production
Mitochondrial respiration generates ROS when electrons prematurely escape electron-transport-chain complexes I and III and react with molecular oxygen to generate superoxide anions 26 
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A r t i c l e s counterparts, as assessed by a red-fluorescent indicator of mitochondrial superoxide (Fig. 5c,d ). The abundance of cytoplasmic ROS was also lower in mFamin −/− M1 macrophages than in mFamin +/+ M1 macrophages, as measured with the cytosolic ROS indicator CM-H 2 DCFDA, although this parameter did not differ between these genotypes in M2 macrophages ( Supplementary Fig. 6a,b) . Stimulation with the Toll-like receptor 2 agonist zymosan resulted in significantly less production of extracellular ROS (eROS) in mFamin −/− M1 and M2 macrophages than in their mFamin +/+ counterparts ( Fig. 5e and Supplementary Fig. 6c ). Inhibition of FASN with C75 or silencing of Fasn through the use of small interfering RNA approximately halved the production of eROS in mFamin +/+ macrophages polarized under M1 or M2 conditions and abrogated the mFamin-associated differences ( Fig. 5e and Supplementary Fig. 6c-e) . Inhibition of CPT1a with etomoxir diminished the zymosan-elicited generation of eROS in mFamin +/+ macrophages to levels observed in mFamin −/− cells, regardless of whether the latter were treated with etomoxir or not ( Fig. 5f and Supplementary Fig. 6f) . A similar pattern of eROS production was observed after silencing of Cpt1a ( Fig. 5g and Supplementary Fig. 6g ) and, notably, after scavenging of mROS ( Fig. 5h and Supplementary Fig. 6h ). As expected, the production of eROS was dependent on the gp91 phox NADPH oxidase 27 , since silencing the gene encoding gp91 phox (Cybb) largely abolished the mFamin-genotype-related differences ( Fig. 5i and Supplementary Fig. 6i) . Notably, mFamin −/− macrophages exhibited diminished generation of eROS relative to that of mFamin +/+ macrophages despite greater availability of NADPH in mFamin −/− macrophages than in mFamin +/+ macrophages ( Supplementary  Fig. 6j ). In contrast to results obtained for macrophages, the production of eROS elicited by the phorbol ester PMA in mouse neutrophils was independent of FAMIN ( Supplementary Fig. 6k ), consistent with absence of mFamin expression in mouse neutrophils 6 (data not shown). In summary, FAMIN controlled mROS production via a DNL-and FAO-dependent mechanism and mROS, in turn, determined the capacity of the NADPH oxidase system to elicit eROS in macrophages. We next investigated whether the metabolic mechanisms elucidated above were affected by genetic variation in mFamin. Wild-type C57BL/ 6N mice have the human 'risk' nucleotide guanine that encodes valine at the corresponding amino acid position 254 (called 'mFamin p254V ' here). Using the CRISPR-Cas9 gene-editing system, we introduced single-nucleotide exchanges and generated mice homozygous for the nucleotide (adenosine) that is protective against leprosy and CD and that encodes isoleucine at amino acid position 254 (mFamin p254I ) 28 ( Supplementary Fig. 3 ). We also generated mice homozygous for the nucleotide (cytosine) at position g.43,883,879 that encodes arginine at amino acid position 284 (the rare mFamin p284R variant linked to monogenic sJIA and early-onset CD in consanguineous families) instead of the highly conserved cytosine at that position (mFamin p284C ) (Supplementary Fig. 3 ). Metabolic flux was equivalent in mFamin p284R macrophages and mFamin −/− macrophages, while mFamin p254I macrophages exhibited the highest ECAR, basal OCR and MU-OCR, and mFamin p254V macrophages had intermediate levels of these ( Fig. 6a-d) . Consistent with such diminished function and loss of function for FAMIN(p.I254V) and FAMIN(p.C284R), respectively, zymosan elicited greater production of eROS from mFamin p254I macrophages than from mFamin p254V cells, while eROS production in mFamin p284R was diminished similar to its decrease in mFamin −/− macrophages ( Fig. 6e and Supplementary Fig. 7a ). The genotype-related differences between mFamin p254I macrophages and mFamin p254V macrophages in zymosan-elicited production of eROS were abolished by the inhibition of FASN with C75 ( Fig. 6f and Supplementary Fig. 7b ).
Overexpression of human FAMIN(p.254I) under control of a cytomegalovirus promoter in HEK293T cells yielded FAMIN expression indistinguishable from that of cells transfected with a construct encoding FAMIN(p.254V) (Fig. 6g) , while expression of FAMIN(p.284R) was low and FAMIN(p.284R) localized together with calreticulin ( Fig. 6g,h) , indicative of retention in the endoplasmic reticulum.
Together our results demonstrated that the substitution p.C284R We next obtained peripheral blood from healthy humans homozygous for the haplotype linked to greater risk of CD and leprosy (rs3764147 G/G ) and the haplotype that is protective against leprosy and CD (rs3764147 A/A ). We isolated primary neutrophils and monocytes from the donors and differentiated the latter in vitro into macrophages under M2 conditions. The expression of FAMIN mRNA in rs3764147 G/G M2 macrophages was indistinguishable from that in rs3764147 A/A M2 macrophages (Supplementary Fig. 7c ). Human rs3764147 G/G M2 macrophages exhibited less zymosan-elicited production of eROS than that of rs3764147 A/A M2 macrophages (Fig. 6i) . In contrast to mouse neutrophils, human neutrophils expressed FAMIN 5 (data not shown). Treatment with PMA triggered lower ROS production in rs3764147 G/G neutrophils than in rs3764147 A/A neutrophils (Fig. 6j) ; this extended the diminished function that resulted from the rs3764147 G/G beyond macrophages. These data demonstrated that the 'risk haplotype' for CD and leprosy (rs3764147 G/G ) was associated with decreased production of eROS. This was a phenocopy of our results obtained with macrophages from mice in which corresponding nucleotides encoding the amino acid at position 254 of FAMIN were edited. Collectively, these results identified the non-synonymous SNP rs3764147 that encodes FAMIN(p.I254V) as the causal genetic variation of this 'risk haplotype' .
Control of bactericidal and inflammasome activity by FAMIN
Finally, we turned our attention to the consequences of the profound metabolic derangement described above on immunological function. mROS can directly augment the bactericidal activity of macrophages directed against intracellular pathogens 29 . mFamin −/− M0 macrophages exhibited significantly less intracellular killing of a luminescent Mycobacterium bovis bacillus Calmette-Guérin (BCG) strain 30 than that of mFamin +/+ M0 macrophages (Fig. 7a) . Silencing FAMIN in human macrophages resulted in diminished bactericidal activity toward luminescent M. bovis BCG (Fig. 7b) , similar to results obtained for mouse macrophages. Finally, more Salmonella enterica serovar Typhimurium were recovered from infected mFamin −/− M0 macrophages than from infected mFamin +/+ M0 macrophages regardless of whether exogenous lipids were provided in serum or not (Fig. 7c) ; these results collectively demonstrated that FAMIN determined the capacity of macrophages to kill intracellular pathogens. mROS also have a critical role in the caspase-1-mediated maturation of interleukin 1β (IL-1β) by the NLRP3 inflammasome 31 . The inflammasome assembles on mitochondria-associated membranes after triggering of cells by pathogen-associated molecular patterns 31 . The activation of mFamin −/− M1 macrophages by the NLRP3 inflammasome via treatment with lipopolysaccharide (LPS) plus ATP resulted in lower levels of cleaved active (p20) caspase-1 than those in mFamin +/+ cells activated similarly. Consequently, there was barely detectable cleaved (p17) IL-1β in the lysates and supernatants of mFamin −/− M1 macrophages, in contrast to the readily detectable IL-1β in mFamin +/+ M1 macrophages (Fig. 7d) . Together these results demonstrated that FAMIN determined the capacity for triggering the NLRP3 inflammasome in M1 macrophages for secretion of the host innate danger signal IL-1β. Moreover, FAMIN-dependent inflammasome activation required intact FAO, as inhibition of FAO (Fig. 7e) , similar to results obtained for zymosan-stimulated M1 macrophages (Fig. 7f) ; no additive effect of the inhibition of FAO was observed for mFamin −/− M1 macrophages (Fig. 7e) . A similar pattern of FAOdependent regulation was observed in LPS-stimulated M1 macrophages for the cytokine TNF and the chemokine CXCL1, while IL-6 secretion remained unaffected (Fig. 7g-i) . Notably, intraperitoneal injection of LPS (2 mg per kg body weight) resulted in lower concentrations of IL-1β, CXCL1 and TNF in serum from mFamin −/− mice than in that from mFamin +/+ mice, while the concentration of IL-6 remained unaffected (Fig. 8a-d) . Notably, this pattern of LPS-induced regulation of serum cytokines is reminiscent of the inhibition of glycolysis in vivo with 2-deoxyglucose 11 . After being stimulated with LPS or with LPS plus ATP in vitro, mononuclear cells from patients with sJIA exhibit much less secretion of IL-1β than do cells from healthy donors, although it has remained unclear whether this is cause or consequence of active disease or is related to therapeutics 32 . Given that the rare SNP variant resulting in the substitution FAMIN(p.C284R) is the only firmly established genetic cause of sJIA so far 1, 33 , impaired induction of IL-1β upon stimulation with LPS and ATP in vitro would be consistent with our results obtained for mFamin −/− M1 macrophages. Nonetheless, blockade of IL-1 is therapeutic in the vast majority of patients with sJIA and leads to swift normalization of their fever, rash and acute-phase reactants 32, 34, 35 . We therefore hypothesized that the profound impairment in 'energetic reserves' in the absence of FAMIN function (reflected by low ATP and phosphocreatine, mitochondrial injury, and diminished FAO and glycolysis) might limit an organism's capacity to withstand serious injury. We injected a high dose of LPS (10 mg per kg body weight) intraperitoneally into mFamin +/+ and mFamin −/− mice and continuously assessed the mice for clinical signs of sepsis over a 3-hour period. mFamin −/− mice had higher sepsis scores than those of mFamin +/+ mice, and these findings were particularly apparent during the first 90 min of observation (Fig. 8e) . Moreover, two of seven mFamin −/− mice also showed signs of epistaxis (consistent with a bleeding disorder), a feature not observed in mFamin +/+ mice (data not shown). The higher sepsis scores of mFamin −/− mice were accompanied by a twofold higher concentration of IL-1β in serum from mFamin −/− mice than in that of mFamin +/+ mice at the conclusion of the experiment (Fig. 8f) . In analysis of 'SNP-mutant' mice, treatment with LPS (at a dose of 10 mg per kg body weight) resulted in the highest concentration of IL-1β in serum from mFamin p254V-284R mice, an intermediate concentration in mFamin p254V-284C mice and the lowest concentration in mFamin p254I-284C mice (Fig. 8g) . Correspondingly, mFamin p254V-284R mice had higher clinical sepsis scores than those of mFamin p254V-284C mice, and mFamin p254V-284C mice had higher clinical sepsis scores than those of mFamin p254I-284C mice (Fig. 8h,i) . Collectively, these results demonstrated that in the absence of FAMIN function, a high dose of LPS led to catastrophic activation of IL-1β. We speculate that the impaired bioenergetic reserves of mFamin −/− mice might tip the balance of sepsis-associated inflammasome activation toward a pyroptotic, pro-death response, as has been reported in other contexts 36 .
DISCUSSION
At the level of the organism, FAO and glucose oxidation are reciprocal metabolic pathways referred to as 'the Randle cycle' 37 . Similarly, coupling of DNL and FAO is not energetically efficient in terms of ATP production but nonetheless are engaged in certain immune and non-immune cells [38] [39] [40] . In macrophages, FAMIN promotes flux through DNL to concomitantly drive high levels of both FAO and glycolysis. FAMIN thereby profoundly determines the maximum bioenergetic capacity of macrophages. The closest orthologs of FAMIN belong to a new class of proteins (the DUF152 ('domain of unknown function 152') family), and those with a reported function are bacterial proteins that exhibit atypical laccase (phenol-oxidoreductase) activity 41, 42 . We purified recombinant eukaryotically expressed human FAMIN(p.254I) and FAMIN(p.254V) and did not observe any laccase activity toward a series of prototypical substrates (data not shown). At this stage, the precise biochemical mechanism whereby FAMIN enhances DNL-dependent FAO remains unclear.
Intriguingly, FAMIN-dependent FAO occurred even when it was uncoupled from ATP synthesis, as in M1 macrophages, and might be of greatest importance in this setting for supporting glycolysis. 'Uncoupled' FAO has been suggested to have a critical role in cancer cells engaged in aerobic glycolysis 43 . Moreover, inhibition of DNL at the level of the acetyl-CoA carboxylase ACC1 (the enzyme that synthesizes the malonyl-CoA required for FASN function) has been reported to impair glycolysis in helper T cells 44 . Here we identified a critical role for FAO in M1 macrophages that was required for IL-1β activation and ROS production. Glycolysis in M1 macrophages is well known to be critically required for IL-1β production 11 . In contrast, the importance of β-oxidation has received less attention, even though FAO, not glycolysis, has been reported to be the sole driver of bactericidal mROS production in Salmonella-infected macrophages 45 . Moreover, FAMIN-dependent mROS production also determines the maximal capacity of the NADPH oxidase system, the main source of bactericidal ROS in M1 macrophages. While metabolic pathways in immune cells are emerging as important determinants of immunological function 46 , we found here that a core metabolic regulator in immune cells was affected by genetic variation that results in a predisposition for inflammatory diseases and infection. Patients with systemic JIA, a condition demonstrated here as arising from a defect at the peroxisome-mitochondria interface, present with a characteristic daily (quotidian) spiking fever 33 . Deficiency in mevalonate kinase, a peroxisomal enzyme involved in cholesterol biosynthesis, causes hyper-IgD syndrome, a related juvenile periodic fever 47 . Remarkably, the mevalonate pathway has a precursor common with that of DNL, cytosolic acetyl-CoA, which raises the possibility of commonality in mechanism. Intriguingly, both sJIA and hyper-IgD syndrome seem to be triggered by childhood infections or vaccinations 33, 47 . Diversity in such environmental triggers might also explain how homozygosity for the loss-of-function FAMIN variant p.C284R can result in two very different diseases, sJIA and early-onset CD 1,2 , an aspect even more pertinent for the FAMIN variant p.I254V, which results in a predisposition for CD.
In summary, we found here that FAMIN controlled acyl-CoA synthesis through DNL at peroxisomes and thereby fed FAO and regulated glycolysis. This has profound implications for cellular energy homeostasis and immunological function in organisms, with hypomorphy promoting autoinflammation.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Mice. Ear-biopsy genomic DNA was used for routine genotyping of all mice. Primer sequences are shown in Supplementary Table 3 . C57BL/6N mice were bred and maintained in specific pathogen-free conditions at the Central Biomedical Services (CBS) facility, University of Cambridge and at the Wellcome Trust Sanger Institute. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted, and all were conducted with approval of the UK home office. mFamin −/− , mFamin p284R and mFamin p254I mice generated as described below littered at Mendelian ratios and developed normally and no spontaneous disease emerged under specific pathogen free (SPF) conditions. Six-to twelve-week-old mice that were age and sex matched as described in the relevant methods sections were used for all experiments unless otherwise stated. mFamin − allele. mFamin −/− mice were generated by disruption of the mouse homolog (9030625A04Rik; Lacc1) of human C13orf31 (LACC1) by homologous recombination in C57BL/6N-A/a embryonic stem (ES) cells ( Supplementary  Fig. 3 ) to generate mice on a pure C57BL/6NTac background (ES cell clone ID EPD0538_1_D06 (International Knockout Mouse Consortium)) 13 .
CRISPR-Cas9 target sites and vector construction. CRISPR target sites were identified using the CRISPR design website (http://crispr.mit.edu/) as described 28 and are shown in Supplementary Table 4 . The strategy to generate mouse lines carrying the p.254I and p.284R FAMIN variants (corresponding residue numbers are identical for human C13orf31 and mouse 9030625A04Rik) is shown in Supplementary Figure 3 . In brief, wild-type C57BL/6NTac mice carry p.254V (human 'risk' variant) and p.284C. For introduction of the 'nonrisk' p.254I allele, guide RNA (gRNA) 'line7' along 'oligo 7' or 'oligo 7 wobble' were used, the latter introducing two additional synonymous nucleotide changes (Supplementary Table 4 and Supplementary Fig. 3) . The corresponding strategy for introduction of the 'Mendelian variant' p.284R with gRNA 'line9' along 'oligo 9' or 'oligo 9 wobble' is shown in Supplementary  Figure 3 . Oligonucleotide tyrex2R (Supplementary Table 4) was co-injected with each of the four lines to target the Tyr gene to allow color-based selection. The selected gRNA sequences were cloned into a gRNA vector containing the gRNA backbone and a T7 promoter to facilitate RNA production (BsaI sites). Cas9 mRNA was produced using a previously described vector modified to contain a T7 promoter 48 . The integrity of all plasmids was confirmed by DNA sequencing. The targeting oligonucleotides were synthesized as desalted ssDNA oligonucleotides from Integrated DNA Technologies (IDT).
Cas9 and gRNA production. For Cas9 RNA production, the T7/Cas9 plasmid was linearized (EcoRI), purified with PCR purification kit (Qiagen) and in vitro transcribed using mMessage mMachine T7 Ultra kit (Life Technologies). For gRNA production, the plasmid was linearized (DraI), purified with PCR purification kit (Qiagen) and in vitro transcribed using the MEGAshortscript T7 kit (Life Technologies). Both Cas9 mRNA and gRNA were purified using the MEGAclear kit (Life Technologies) and were eluted in RNase-free water. The quality of the RNA was analyzed using Agilent RNA 6000 Nano kit (Agilent Technologies, 2100 Bioanalyzer) and Qubit RNA BR assay kit (Thermo Fisher Scientific).
One-cell embryo injection. Twelve 4-to 5-week old C57BL/6NTac females were super-ovulated by intraperitoneal injection of 5 IU of pregnant mare's serum (PMSG) at 12:00-13:00 h (on a 12 h light/dark cycle, on at 07:00/off at 19:00) followed 48 h later by an intraperitoneal injection of 5 IU human chorionic gonadotrophin (hCG) and were mated overnight with C57BL/6NTac stud males. The next morning the females were checked for the presence of a vaginal copulation plug as evidence of successful mating, and oviducts were dissected at approximately 21-22 h post hCG. Cumulus masses from these were released and treated with hyaluronidase, and the fertilized one-cell embryos were left in KSOM media ready for cytoplasmic injection, as previously described 49 . 50 ng/µl Cas9 mRNA, 25 ng/µl gRNA and 100 ng/µl oligonucleotide were mixed in RNase-free water and injected into the cytoplasm of fertilized onecell embryos in FHM medium. One-cell injected embryos were transferred the same day by oviductal embryo transfer into 0.5 d post-coital pseudo-pregnant female BJCB strain (CBA<Wtsi>;C57BL/6J-Jax F1) recipients, produced by estrus selection and overnight mating to vasectomized males 49 .
Cytoplasmic injection. Injections were performed using a new cytoplasmic injection technique. An injector using a positive balance pressure, such as an Eppendorf Femtojet, was connected to a microinjection tip filled with the CRISPR materials. The microinjection tip was steadily advanced toward the opposite side of the zygote, which was anchored by the holding pipette until the micropipette passed through the plasma membrane to break it. The pipette was then drawn back into the cytoplasm, the CRISPR mix was delivered and the micropipette was immediately withdrawn. A successful injection was indicated by visible movement in the cytoplasm.
SNP-mutant-mice breeding strategy. Illumina sequencing of the mFamin gene was used in founder and F1 generation mice, confirmed by Sanger sequencing, to assess for successful gene editing. Founder mice were crossed with wildtype C57BL/6NTac mice to generate mFamin p254I/p254V and mFamin p284R/p284C heterozygous mice, which were then intercrossed, and homozygous littermates were used for experiments. Mice generated with and without wobble bases in targeting oligonucleotides were maintained separately and were used in experiments alongside their littermate controls irrespective of the presence or absence of wobble bases. Offspring from several founders were used to populate genotype categories in experiments. Routine genotyping was performed via Sanger sequencing.
Genotype-selected human samples. Peripheral blood for human neutrophil and monocyte isolation was collected from healthy volunteers from a genotype-selectable bioresource of ~10,000 donors (Cambridge BioResource; http:// www.cambridgebioresource.org.uk). Healthy age-and sex-matched donors identified as homozygous for the 'risk haplotype' (G/G) or 'non-risk haplotype' (A/A) at SNP rs3764147, encoding FAMIN(p.254V) and FAMIN(p.254I) respectively, were recruited to participate in the study. Nucleotide positions in text correspond to genome assembly GRCh38.p2. None of the volunteers had received corticosteroid or immunosuppressant therapy within 6 months of enrollment. Investigators were kept blinded to the genotype of samples until study completion, with all individual experimental procedures performed on ('blinded') genotype pairs. The study protocol has been reviewed and approved by the South Central Berkshire B Research Ethics Committee (15/SC/0068), and written informed consent was obtained from each subject. Mouse bone-marrow-derived macrophages and neutrophils. Bone marrow was flushed from mouse femurs and tibias, filtered through a 70 µm cell strainer and incubated in complete medium (RPMI-1640 containing 100 U/ml of penicillin-streptomycin, 1 mM HEPES pH 7.4) and 10% FBS. Bone-marrow-derived macrophages (BMDMs) were prepared by culturing cells for 6 d in the presence of 100 ng/ml of M-CSF. After harvesting and npg re-seeding, macrophages were polarized for 16 h toward M1 or M2 with IFN-γ (50 ng/ml) plus LPS (20 ng/ml) or with IL-4 (20 ng/ml), respectively, and where indicated, in the presence or absence of C75 (20 µM) and etomoxir (100 µM). Bone-marrow neutrophils were prepared using a neutrophil isolation kit (Miltenyi Biotec) according to the manufacturer's instructions.
Human peripheral-blood-derived macrophages. For studies of human cells, blood received from healthy donors was used to isolate peripheral blood mononuclear cells and neutrophils by Lymphoprep (Axis-Shield) gradient centrifugation. Monocyte-derived macrophages were generated by resuspending cells in complete RPMI-1640 and plated on Nunclon surface tissue culture dishes (Nunc). After 2 h, non-adherent cells were discarded and the remaining monocytes cultured for 4 d in complete medium with 10% FBS and 40 ng/ml M-CSF. At day 4, macrophages were harvested and polarized into M1 and M2 as described for mouse macrophages. Neutrophils were concurrently isolated during Lymphoprep gradient centrifugation (Axis-Shield) by sedimentation of the red blood cell-neutrophil layer with 10% dextran, followed by hypotonic lysis of contaminating erythrocytes.
Cell lines. THP-1 and U937 cell lines were maintained in complete RPMI-1640 with 10% FBS. To polarize into M1 macrophages, cells were incubated overnight with 50 ng/ml IFN-γ plus 20 ng/ml LPS and for M2 macrophages, cells were treated with 1 µM of PMA for 6 h and then polarized with 50 ng/ml IL-4 and 50 ng/ml IL-13. HEK293 and HEK293T cells were maintained in DMEM with 10% FBS. All cell lines were purchase from ATCC, which guarantees cell-line authentication.
Plasmids. The gene encoding human FAMIN (C13orf31 (LACC1); called 'FAMIN' below) was amplified from an IMAGE clone (MHS1010-7508636) using a forward primer containing a KpnI site followed by a Kozak sequence and start codon and reverse primer containing a BamHI site, excluding the stop codon of FAMIN and was cloned into KpnI and BamHI digested and dephosphorylated pEXPR-IBA103 (IBA Life Sciences) to generate C-terminal Strep III tag FAMIN. The same IMAGE clone was amplified with a forward primer containing a SacII site and a reverse primer containing an XhoI site and cloned into pEXPR-IBA105 to generate N-terminal Strep III tag FAMIN. Strep-tag III is a sequential arrangement of two Strep-tag II sequences (Trp-Ser-His-Pro-Gln-Phe-Glu-Lys) separated by a short linker. Constructs were sequence verified, with Strep-tag III in-frame with FAMIN. FAMIN containing a stop codon was also cloned into pEXPR-IBA103 for use as an untagged FAMIN control.
FAMIN variants were introduced by site-directed mutagenesis (Agilent Quick change II XL SDM kit) using the above constructs as template. To introduce the p.254V substitution, the following primers were used: Forward, 5′-A GACTCATCATTCCAATGACGTCTGGATTATGGGAAGAAAG-3′; Reverse, 5′-TAAAGACTCATCATTCCAATGACATCTGGATTATGGGAAGAAAGG AG-3′ and to introduce the p.284R mutation the following primers were used: Forward, 5′-CAAAAACTATCGGTATACGGTCTGCACCAAGAGCTGC-3′; Reverse 5′-GCAGCTCTTGGTGCAGACCGTATACCGATAGTTTTTG-3′. All constructs were sequence verified in both forward and reverse orientations.
Protein affinity-purification mass spectrometry. HEK293T cells were transfected with pEXPR-IBA103 vector only or plasmid constructs encoding untagged FAMIN, N-terminal Strep-tag FAMIN or C-terminal Strep-tag FAMIN using Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions. 48 h following transfection, cells were washed twice in ice-cold PBS and harvested by gently scraping into 5 ml ice-cold lysis buffer containing 20 mM HEPES-KOH, pH 7.5, 150 mM KCl, 1% Nonidet P-40, 0.1 mM phenylmethylsulfonyl fluoride, and protease inhibitor mixture. Cells were incubated on ice for 10 min, then were homogenized by shearing 20 times through a 21-gauge needle. The protein lysate was centrifuged for 15 min at 4 °C at 3,000g and the protein supernatant was collected into a freshly chilled tube to remove cellular debris. 1 U/ml of avidin was added to block endogenous biotin and incubated on ice for 15 min and then re-centrifuged for a further 10 min at 4 °C. Supernatant containing Strep-tag labeled FAMIN protein was precipitated using a Strep-Tactin column (IBA Life Sciences). Streptagged FAMIN protein complexes were eluted using 2.5 mM desthiobiotin and eluted fractions were subjected to SDS-PAGE separation, followed by silver staining or immunoblot analysis. Gels were submitted to the Cambridge Centre for Proteomics, Department of Biochemistry and were excised manually. Proteins were reduced, carboxyamide methylated, and then digested to peptides using trypsin on a MassPrepStation (Micromass). The resulting peptides were applied to liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) on a QTof (Micromass). Fragmentation data were used to search the National Center for Biotechnology Information database using the MASCOT search engine (http://www.matrixscience.com).
Lipid mass spectrometry. Day-6 macrophages were seeded at 5 × 10 6 cells per 60 mm dish and polarized under M1 or M2 conditions. Cells were harvested, washed twice in ice-cold PBS and then flash-frozen in liquid nitrogen. For 1, 2-13 C-glucose-tracing experiments, macrophages were polarized overnight and then cultured for 24 h in the presence of 10 mM 1,2-13 C-glucose (Sigma). Cell pellets were washed twice with cold PBS and re-suspended in 1.5 ml methanol. After spiking with 40 µl lipid standards cocktail mix of 50 ng 17:0-FaCN, 100 ng 17:0-FaCoA and 400 ng 17:0-FFA, 1.5 ml of LCMS-grade water and 3 ml chloroform were added in. The mixture was subjected to Folch extraction. After collection of the lower phase, the upper phase was re-extracted with 3 ml synthetic lower phase (chloroform/methanol/water at volume ratio of 2:1:1, using the lower phase for re-extraction of lipid). The lower phase from both extractions was combined and dried under vacuum at 20 °C with SpeedVac (Thermo) and re-dissolved in 100 µl chloroform. 7 µl were injected for LC/ MS/MS analysis. A Thermo Orbitrap Elite system (Thermo Fisher) hyphenated with a five-channel online degasser, four-pump, column oven, and autosampler with cooler Shimadzu Prominence HPLC system (Shimadzu) was used for lipid analysis. In detail, lipid classes were separated on a normal-phase Cogent silica-C column (150 × 2.1 mm, 4 µm, 100 Å, MicoSolv Technology) with hexane/dichloromethane/chloroform/methanol/acetanitrile/water/ethylamine solvent gradient based on the polarity of head group. High resolution (240k at m/z 400) / accurate mass (with mass accuracy <5 ppm) were used for molecular species identification and quantification. The identity of lipid was further confirmed by reference to appropriate lipids standards. Orbitrap Elite mass spectrometer operation conditions were as follows. For positive ion analysis: heated ESI source in positive ESI mode; heater temperature, 325 °C; sheath gas flow rate (arb), 35; aux gas flow rate (arb), 5; sweep gas flow rate (arb), 0; I spray voltage, 3.5 kV; capillary temperature, 325 °C; and S-lens RF level, 60%. Orbitrap mass analyzer was operated as SIM scan mode with two events. Event 1: mass range, m/z 238-663; and mass resolution, 240 k at m/z 400. Event 2: mass range, m/z 663-1088; and mass resolution, 240 k at m/z 400. B. For negative ion analysis, heated ESI source in negative ESI mode; heater temperature, 325 °C; sheath gas flow rate (arb), 45; aux gas flow rate (arb), 10; sweep gas flow rate (arb), 0; I spray voltage, 3.0 kV; capillary temperature, 375 °C; and S-lens RF Level, 70%. Orbitrap mass analyzer was operated as SIM scan mode with two events. Event 1: mass range, m/z 218-628; and mass resolution, 240 k at m/z 400. Event 2: mass range, m/z 628-1038; and mass resolution, 240 k at m/z 400. All the solvents used for lipids extraction and LC/MS/MS analysis are LC-MS grade from FisherScientific.
Aqueous metabolites mass spectrometry. Metabolites were extracted from 5 × 10 6 macrophages using methanol/chloroform. The organic and aqueous fractions were separated by the addition of water and chloroform. The aqueous layer was analyzed subsequently for metabolomics. Mass spectrometry was performed on an AB Sciex 5500 (Warrington) coupled to an Acquity ultra performance liquid chromatography (UPLC) system from Waters. For chromatography of Krebs-cycle intermediates, metabolites were separated on a BEH amide HILIC column (100 × 2.1 mm, 1.7 µm; Waters) in negative ion mode. After drying, the samples were analyzed on a HSS T3 column (100 × 2.1 mm, 1.7 µm; Waters). Cone voltage, collision energy and mass transitions were optimized for each metabolite for quantification. Data are presented in arbitrary units as the area ratio of metabolite peak relative to the internal standard.
ATP assay. ATP content in total cell lysates was measured using an ATP determination kit (Molecular probes, A22066). M1 and M2 macrophages were trypsinized after an overnight polarization and counted, and 2 × 10 5 cells were lysed in 100 mM Tris pH 7.75, 4 mM EDTA and 1% Triton-X.
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Silver staining. Polyacrylamide gels were fixed for 1 h at 20 °C in 40% ethanol with 10% acetic acid. Gels were washed overnight with distilled water and then sensitized with 0.02% sodium thiosulphate for 1 min, washed and then stained for 20 min at 4 °C with 0.1% silver nitrate with 0.02% formaldehyde. Gels were developed with 3% sodium carbonate with 0.05% formaldehyde and staining was terminated with 5% acetic acid for 5 min.
Immunofluorescence staining. Cells were seeded on glass coverslips and differentiated overnight as required. Cells were fixed with 4% paraformaldehyde containing either 0.2% or 1% Triton X-100 for 15 min at 20 °C or 100% methanol at −20 °C for 15 min. Fixed cells were washed with PBS and non-specific binding was blocked with either 5% normal serum or 0.5% milk before incubation with primary antibodies for 1 h at 20 °C. Unbound antibody was removed by washing with PBS and secondary antibody was bound for 30 min at 20 °C. Coverslips were then mounted with either Prolong or Mowiol mountant containing DAPI. Fluorescence was visualized with a Zeiss LSM 510 or a DeltaVision Spectris Deconvolution Microscope.
Proximity-ligation assay. Cells were fixed and stained with primary antibody as described above for immunofluorescence. Proximity-ligation assay (PLA) was performed as per the manufacturer's instructions (Duolink In situ, Olink Bioscience). In brief, unbound antibody was removed by washing twice for 5 min with 1× wash buffer A and PLA probes were bound for 1 h at 37 °C. Unbound PLA probes were removed by washing twice for 5 min with 1× wash buffer A. Coverslips were incubated with Ligation-Ligase solution for 30 min at 37 °C. Ligation-Ligase solution was removed by washing twice for 2 min with 1× wash buffer A and coverslips were incubated with AmplificationPolymerase solution for 100 min at 37 °C. Amplification-Polymerase solution was removed first by washing twice for 10 min with 1× wash buffer B and second by washing 1 min with 0.01% wash buffer B. Coverslips were then mounted and fluorescence was visualized as described for immunofluorescence staining.
Oil Red O staining. Macrophages were seeded onto glass coverslips and allowed to differentiate overnight. Cells were washed twice with PBS and then incubated for 3 min in 100% propylene glycol (VWR) before staining with Oil Red O solution (0.5% Oil Red O [Amresco] in propylene glycol) for 10 min at 20 °C. Excess stain was removed by washing with 85% propylene glycol and washing with distilled water. Cells were counterstained with hematoxylin and mounted with Kaiser's glycerol gelatine (Merck Millipore).
Transmission electron microscopy. Cells were fixed in 4% glutaraldehyde in 0.1 M HEPES (pH 7.4) for 12 h at 4 °C, washed with 0.1M HEPES 5 times and then treated with 1% osmium ferricyanide at 20 °C for 2 h. Cells were rinsed in water five times and treated with 2% uranyl acetate in 0.05 M maleate buffer (pH 5.5) for 2 h at 20 °C, rinsed and dehydrated in an ascending series of ethanol solutions (70% to 100%) and then were treated with two changes of dry acetonitrile before infiltration with Quetol epoxy resin. Images were taken in an FEI Tecnai G2 operated at 120 Kv using an AMT XR60B digital camera running Deben software.
Quantitative real-time PCR. Total RNA was isolated from cultured cells and tissues using RNeasy Mini Kit (QIAGEN) according to the manufacturer's instructions. For RT-PCR, cDNA was synthesized using oligo(dT) primers and M-MLV reverse transcriptase followed by quantitative PCR analysis. The primers are shown in Supplementary Table 5 .
Statistical analysis. Statistical significance was calculated as appropriate using an unpaired, two-tailed Student's t-test, Mann-Whitney U-test or analysis of variance and Bonferroni's test and Grubb's test for outlier exclusion, as described in the figure legends. Data is represented as mean and s.e.m. (s.e.m.). A P value of <0.05 was considered significant. Data were analyzed with Graphpad Prism software (version 6).
